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ABSTRACT
Protein ubiquitination plays an important role in
activating the DNA damage response and maintain-
ing genomic stability. In response to DNA
double-strand breaks (DSBs), a ubiquitination
cascade occurs at DNA lesions. Here, we show
that checkpoint with Forkhead-associated (FHA)
and RING finger domain protein (CHFR), an E3 ubi-
quitin ligase, is recruited to DSBs by
poly(ADP-ribose) (PAR). At DSBs, CHFR regulates
the first wave of protein ubiquitination. Moreover,
CHFR ubiquitinates PAR polymerase 1 (PARP1)
and regulates chromatin-associated PARP1 in vivo.
Thus, these results demonstrate that CHFR is an
important E3 ligase in the early stage of the DNA
damage response, which mediates the crosstalk
between ubiquitination and poly-ADP-ribosylation.
INTRODUCTION
Cells encounter numerous environmental and internal
hazards that cause DNA lesions, such as DNA double-
strand breaks (DSBs). Through evolution, cells have de-
veloped sophisticated cell cycle checkpoint system and
DNA damage repair machineries to repair lesions and to
maintain genomic stability (1,2). During these cellular
events, protein post-translational modiﬁcations, including
ubiquitination, phosphorylation, sumoylation, methyla-
tion, acetylation and ADP-ribosylation, play important
roles in mediating DNA damage repair (2–17).
Among these modiﬁcations, a ubiquitination cascade
mediated by a group of E2 and E3 enzymes occurs at
DSBs. One major E3 ligase that controls this ubiq-
uitination cascade is RNF8. In response to DSBs, RNF8
recognizes phospho-MDC1, a functional partner of
gH2AX, and works together with Ubc13 to catalyze
histone ubiquitination at DSBs (18–26). It is also
reported that RNF8 associates with other E2 conjugases,
such as UbcH5, which may be responsible for the displace-
ment of KU80 at DNA damage sites (27). The RNF8-
dependent ubiquitin signals recruit other E3 ligases
including RNF168, RAD18 and HERC2, to DNA
damage sites for the ampliﬁcation of the ubiquitin
cascade (4,28–38). The ampliﬁed ubiquitination at DSBs
is important for recruiting DNA damage repair proteins
such as BRCA1 and 53BP1 to DNA damage sites and for
fulﬁlling their repair functions (19–22,26,31).
In addition to RNF8, another E3 ligase CHFR also
participates in the DNA damage response initiation (39).
Like RNF8, CHFR contains Forkhead-associated (FHA)
domain and RING domain (40). Particularly, the RING
domain of CHFR is interchangeable with the RING
domain of RNF8 (41), suggesting that CHFR and
RNF8 share the same E2 partners and have overlapping
functions during the DNA damage response. Like the
RING domain of RNF8, the RING domain of CHFR
works together either with Ubc13 to catalyze K63-linked
poly-ubiquitin chains or with UbcH5C to catalyze
K48-linked poly-ubiquitin chains (42). Using genetic
approach, we have shown that loss of CHFR and RNF8
additively induces genomic instability and suppresses the
DNA damage response (39), which is in agreement with
many previous reports that CHFR plays an important
role in tumour suppression (40,43–47). In contrast with
RNF8, CHFR contains a Cys-rich domain and a
poly(ADP-ribose) (PAR)-binding zinc ﬁnger (PBZ) motif
at the C-terminus that recognizes PAR (48,49).
ADP-ribose is covalently conjugated at DNA damage
sites as a branched polymer for DNA damage repair
(48–50). It suggests that CHFR has a unique function
during the DNA damage response distinct from that of
RNF8. Here, we report that CHFR is recruited to DNA
damage sites by PAR. CHFR ubiquitinates PAR polymer-
ase 1 (PARP1), the major PAR polymerase and regulates
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chromatin-associated PARP1 in vivo. CHFR-dependent
protein ubiquitination accounts for the ﬁrst wave of
protein ubiquitination at DNA damage sites.
MATERIALS AND METHODS
Generation and culture of mouse embryonic ﬁbroblasts
The generation of wild-type, Rnf8/, Chfr/ and double
knockout (DKO) mouse embryonic ﬁbroblasts (MEFs)
was described (39,51). All the MEFs were maintained in
the Dulbecco’s modiﬁed Eagle medium with 10% fetal
bovine serum. For the ionizing radiation (IR) treatment,
cells were irradiated with a JL Spepherd 137Cs radiation
source with indicated doses. Following IR treatment, cells
were maintained in the culture conditions for indicated
time points. For the PARP1 inhibitor treatment, the
cells were cultured in the Dulbecco’s modiﬁed Eagle
medium with 10 mM PJ34 (EMD4Bioscience) for 1 h,
then subjected to following experiments.
Plasmids and antibodies
CHFR, RNF8 and PARP1 cDNAs were subcloned into
pEGFP-N1 vector. The deletion mutants of CHFR were
generated by using the QuikChange site-directed mutagen-










GT-GAACAGACAAGGTTCAA-30 and -PBZ-a: 50-TTG
AACCTTGTCTGTTCACAGGATGTTACGGCCACT
GG-CA-30. siRNA for mouse Parp1: 50-AAGCCCCCACU
CCUGAACAACUU-30. siRNA for human Parp1: 50-AAC
CCCAAAGGAATTCCGAGAUU-30.
Rabbit anti-CHFR antibody was raised against the
RING domain of CHFR (residue 259–488) as described
before (51). Monoclonal and polyclonal anti-mouse
gH2AX antibodies, monoclonal anti-ubiquitin (FK2)
antibody, polyclonal anti-histone H4, monoclonal and poly-
clonal anti-myc and anti-glutathione s-transferase (GST)
antibodies, monoclonal anti-GAPDH antibodies were
purchased from Upstate. Monoclonal anti-PAR antibody
was purchased from Genetex. Rabbit monoclonal
anti-PARP1 (46D11) antibody was purchased from Cell
Signaling Technology. Human anti-K48 and anti-K63
poly-ubiquitin antibodies were purchased from Genentech.
We performed cell transfection and immunoblotting using
standard protocols.
Laser microirradiation, immunoﬂuorescence staining and
microscope image acquisition
For laser microirradiation, cells were grown on 35-mm
glass bottom dishes (MatTek Corporation). Laser
microirradiation was performed on OLYMPUS IX71
inverted ﬂuorescence microscope with a Micropoint
Laser Illumination and Ablation System (Photonic
Instruments). The laser output was set to 40%, which
can reproducibly give a focused gH2AX stripe. For
time-lapse microscopic analysis, cells were ﬁrst transfected
with corresponding plasmids. Then, green ﬂuorescent
protein (GFP) positive cells were subjected to
microirradiation. The GPF strips were recorded at
indicated time points and then analysed with Image J
software. For the time course analysis of laser
microirradiation, samples were subjected to continuous
microirradiation along certain paths within the indicated
time interval. Then, the samples were subjected to im-
munoﬂuorescence staining with indicated antibodies. For
immunoﬂuorescence staining, cells were ﬁxed in 3%
paraformaldehyde for 10 min and permeabilized with
0.5% Triton X-100 in phosphate-buffered saline (PBS)
for 5 min at room temperature. Samples were blocked
with 8% goat serum and then incubated with the
primary antibody for 1 h. Samples were washed for three
times and incubated with the secondary antibody for 30
min. The coverslips were mounted onto glass slides and
visualized with OLYMPUS IX71 inverted ﬂuorescence
microscope. All the images were acquired with cellSens
standard (Version 1.3) software under OLYMPUS IX71
inverted ﬂuorescence microscope equipped with a
UPlanSApo 60/1.35 oil immersion objective at room
temperature. Identical contrast and brightness adjust-
ments were used on images for all given experiments.
PARP1 auto-PARylation and in vitro and in vivo
ubiquitination assay
To auto-PARylate His-PARP1, 100 mg puriﬁed His-
PARP1 protein binding on the Ni Sepharose (GE
healthcare) beads was incubated for 30 min at 30C in
the PARylation buffer (100mM Tris–HCl (pH 7.6),
10mM MgCl2, 50 mg DNA octamer (50-GGAATTCC-30)
and 10mM DTT), with or without 4mM NAD+
(CALBIOCHEM). Then, the beads were washed for
three times with PBS.
For in vitro ubiquitination assay, 1 mg HA-Ub, 200 ng
E1, 300 ng UbcH5C or Ubc13/Uev1a (all from Boston
Biochem), 500 ng GST-CHFR or other indicated mutant
proteins puriﬁed from sf9 cells, 1 mg His-PARP1 or
PARylated His-PARP1 binding on Ni Sepharose beads
were incubated in the reaction buffer (50mM Tris–HCl
pH 7.5, 5mM MgCl2, 100mM NaCl and 0.5mM DTT)
at 30C for 30 min. Then, the beads were thoroughly
washed with ice-cold PBS and boiled with sodium
dodecyl sulphate (SDS) sample buffer. Ubiquitinated
proteins were resolved on 4–15% SDS–polyacrylamide
gels (TGXTM, BioRad).
For in vivo ubiquitination assay, 5 mg of myc-CHFR or
other indicated mutant plasmids were transfected into
HCT116 cells with Lipo2000 (Invitrogen). Twenty-four
hours after transfection, the cells were treated with
10 Gy of IR and replaced with fresh media in the
presence of dimethyl sulfoxide (DMSO) or 10 mM
MG132 for 30 min. Then, the cells were lysed with











NETN300 (20mM Tris–HCl, pH 8.0, 300mM NaCl,
1mM ethylenediaminetetraacetic acid (EDTA) and 0.5%
NP-40) on ice for 10 min. Equal amount of proteins from
the cell lysates were incubated with protein A beads and
anti-PARP1 antibody for 2 h at 4C. Then, the beads were
thoroughly washed with ice-cold PBS and boiled with SDS
sample buffer. Proteins were resolved on 4–15%
SDS-polyacrylamide gels (TGXTM, BioRad) and analysed
by immunoblotting with indicated antibodies.
Chromatin fraction
Cells were harvested at indicated time points after 10Gy
of IR treatment and washed twice with PBS. Cell pellets
were subsequently resuspended in the NETN buffer
(20mM Tris–HCl, pH 8.0, 100mM NaCl, 1mM EDTA
and 0.5% NP-40) and incubated on ice for 10 min.
Thereafter, insoluble fraction was recovered and resus-
pended in 0.2 M HCl. The soluble fraction was neutralized
with 1M Tris–HCl pH 8.0 for further analysis.
Alkali comet assays
Single-cell gel electrophoretic comet assays were per-
formed under alkaline conditions. Brieﬂy, 24 h after elec-
troporation of indicated plasmids or transfection with
indicated siRNA, MEFs were irradiated with or without
5Gy of IR and recovered in normal culture medium for
indicated time at 37C. Cells were collected and rinsed
twice with ice-cold PBS; 2  104/ml cells were combined
with 1% LMAgarose at 40C at the ratio of 1:3 (v/v) and
immediately pipetted onto slides. For cellular lysis, the
slides were immersed in the alkali lysis solution (1.2 M
NaCl, 100mM EDTA, 0.1% SDS and 0.26 M NaOH,
pH > 13) overnight at 4C. Then, the slides were subjected
to electrophoresis at 15 V for 25 min (0.6 V/cm) and
stained in 10 mg/ml propidium iodide for 20 min. All
images were taken with a ﬂuorescence microscope and
analysed by Comet Assay IV software.
Colony formation assay
One thousand cells were plated in the wells of a 6-well
plate immediately after radiation. After incubation for
10 days, the surviving cell fractions were calculated by
comparing the numbers of colonies formed in the
irradiated cultures with those in untreated control.
GST pulldown assay
Two micrograms of GST or GST-CHFR proteins ex-
pressed and puriﬁed from Escherichia coli were incubated
with 10 mg His-PARP1 or auto-PARylated His-PARP1
protein with Glutathione Sepharose 4B beads (GE
Healthcare) at 4C for 2 h with rotation. Then, the
beads were thoroughly washed in ice-cold PBS for ﬁve
times and then boiled in the SDS sample buffer for
further analysis.
RESULTS
CHFR is rapidly recruited to laser-induced DNA
damage sites
To search for the role of CHFR in the DNA damage
response, we examined whether CHFR could be recruited
to DNA damage sites. We engineered an EGFP tag at the
C-terminus of CHFR and monitored CHFR’s localization
in response to laser-induced DNA damage. Interestingly,
CHFR is instantly recruited to DNA damage sites and
colocalized with gH2AX, a surrogate marker of DNA
damage sites (Figure 1A). Moreover, endogenous CHFR
also relocated to DNA damage sites, suggesting that
CHFR directly participates in the DNA damage
response (Figure 1B and Supplementary Figure S1). We
found that the recruitment of CHFR to DNA damage
sites was very unique and different from other reported
E3 ubiquitin ligases (21,31). We carefully measured the
kinetics of the relocation of CHFR. As shown in
Figure 1C, CHFR was recruited to lesions within a few
seconds following DNA damage and was dropped off
from DNA damage sites in 10 min. We checked multiple
cells with different GFP-CHFR expression levels and
found similar kinetics of recruitment to DNA damage
sites (Supplementary Figure S2), which excludes the pos-
sibility that protein expression level affects the kinetics of
recruitment. We also checked the endogenous CHFR
kinetics after laser microirradiation and found similar
kinetics to the exogenous over-expressed protein
(Supplementary Figure S1B), suggesting that CHFR can
be quickly recruited to DNA damage sites to participate in
the DNA damage response. In contrast to the fast recruit-
ment of CHFR to DNA damage sites, consistent with
other reports, RNF8 started to be recruited to lesions
1min after DNA damage, gradually accumulated at
DNA damage sites in the ﬁrst 15 min and was kept at
DNA damage sites in a steady state at least for 1 h
(Figure 1C and D) (21,31).
CHFR regulates the ﬁrst wave of ubiquitination events at
DNA damage sites
The difference in kinetics between CHFR and RNF8 at
DNA damage sites indicates that these two E3 ligases may
regulate ubiquitination events at different stages of DNA
damage response. Using genetic tools that we have
generated (39), we next examined the kinetics of ubiquitin
conjugation at DNA damage sites in wild-type, Chfr/,
Rnf8/ and DKO MEFs. In wild-type MEFs, DNA
damage-induced ubiquitination could be clearly visualized
within a couple of minutes following DNA damage
(Figure 2). However, this cellular process was signiﬁcantly
delayed in Chfr/ MEFs; whereas gH2AX at DNA
damage sites was not affected in the absence of CHFR.
In contrast, in Rnf8/ MEFs, although ubiquitin was still
quickly conjugated at DNA damage sites, the intensity of
ubiquitin signals was quickly reduced to undetectable
levels. In the absence of CHFR and RNF8, we could
not detect protein ubiquitination at DNA damage sites.
Thus, these results indicate that CHFR mainly regulates
early ubiquitination events during the DNA damage











response, which accounts for the ﬁrst wave of protein
ubiquitination at DNA damage sites.
PAR mediates the recruitment of CHFR to DNA damage
sites
Next, we examined the mechanism by which CHFR is
targeted to DNA damage sites. Interestingly, CHFR can
be recruited to DNA damage sites in the absence of H2AX
and MDC1 (Supplementary Figure S3), suggesting that
other mechanisms instead of gH2AX target CHFR to
DNA damage sites. As CHFR contains four different
domains, namely the N-terminal FHA domain, the
RING domain, the Cys-rich domain and the C-terminal
PBZ motif (Figure 3A), we deleted each domain of CHFR
and found that loss of PBZ motif but not other domains
clearly abolished the relocation of CHFR to DNA
damage sites (Figure 3B). As the PBZ motif of CHFR
recognizes PAR (48), it is likely that PAR mediates the
relocation of CHFR to DNA damage sites. PAR is mainly
synthesized by PARP1 and is covalently conjugated to
PARP1 itself at DNA lesions immediately following
DNA damage (10,52). PARP inhibitor PJ34 can efﬁciently
suppress PAR synthesis at DNA damage sites (53–55).
Thus, with PJ34 treatment, CHFR failed to be recruited
to DNA damage sites (Figure 3C). Moreover, we depleted
PARP1 in U2OS cells by siRNA knockdown, the
CHFR DAPIGFP-CHFR γH2AX γH2AXDAPIA B
C GFP-CHFR
GFP-RNF8
0 min 0.25 min 0.5 min 1 min 2 min 5 min
10 min 15 min 20 min
0 min 0.25 min 1 min 2 min 5 min
10 min 15 min 20 min 40 min
0.5 min
60 min

















Figure 1. CHFR is recruited to DNA damage sites. (A) Laser microirradiation induces recruitment of GFP-CHFR to DNA damage sites in U2OS
cells. (B) Endogenous CHFR is recruited to DNA damage sites. U2OS cells were ﬁxed immediately following laser microirradiation and subjected to
immunoﬂuorescence staining with polyclonal anti-CHFR and monoclonal anti-gH2AX antibodies. (C) Dynamic recruitment of GFP-CHFR and
GFP-RNF8 to DNA damage sites in U2OS cells following laser microirradiation. (D) Different kinetics of the recruitment of CHFR and RNF8 to
DNA damage sites are summarized. The highest GFP intensity was calculated as 100% in each cell, and kinetics of the recruitment were plotted.
Data were analysed from 20 cells in each experiment. Data were presented as mean±SD. Bars, 10 mm.











recruitment of CHFR to DNA damage sites was signiﬁ-
cantly suppressed (Figure 3D). Collectively, these results
demonstrate that PAR mediates the relocation of CHFR
to DNA damage sites.
CHFR ubiquitinates PARP1 and regulates the chromatin-
associated PARP1 following DNA damage
As we reported previously, histones are substrates of
CHFR and RNF8 during DNA damage (39). We
wondered whether CHFR has other substrates during its
recruitment to DNA damage sites. As PARP1 itself is a
major target of PARylation after DNA damage (52), we
hypothesized that CHFR may ubiquitinate PARP1
through recognizing PAR on PARP1. We ﬁrst puriﬁed
His-tagged PARP1 or in vitro PARylated His-tagged
PARP1 and performed in vitro ubiquitination assays. As
shown in Figure 4A and B, CHFR can ubiquitinate
PARylated PARP1 but not the unmodiﬁed PARP1 with
either UbcH5C or Ubc13/Uev1a as the E2 enzyme. These
A
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Figure 2. CHFR regulates the ﬁrst wave of protein ubiquitination at DNA damage sites. Wild-type (WT), Chfr/, Rnf8/ or DKO MEFs were
treated with laser microirradiation and then ﬁxed at the indicated time points. The ubiquitin (detected by FK2 antibody) and gH2AX at DNA
damage sites were then examined by immunoﬂuorescence staining. (A) Representative cells at different time point in each MEF were shown. (B) Cells
with colocalized ubiquitin and gH2AX signals were counted as Ub positive cells. The percentage (mean±SD) of Ub positive cells at different time
point was summarized from 100 cells. Bar, 10 mm.











two different E2 enzymes catalyze K48-linked and
K63-linked poly-ubiquitin chain on PARylated PARP1,
respectively. Moreover, the RING domain deletion (R)
or PBZ motif deletion (P) mutants cannot ubiquitinate
PARP1 or PARylated PARP1 in vitro, suggesting that
both the E3 ligase of CHFR and the interaction between
CHFR and PAR are important for the ubiquitination of
PARP1. Consistently, recombinant CHFR directly bound
PARylated PARP1 but not unmodiﬁed PARP1































































































Figure 3. PAR mediates the recruitment of CHFR to DNA damage sites. (A) Domain architecture of GFP-tagged wild-type CHFR (WT), FHA
domain deletion mutant (FHA), RING domain deletion mutant (RING), Cys-rich domain deletion mutant (CRD) and PBZ motif deletion
mutant (PBZ). (B) The PBZ motif is required for the relocation of CHFR to DNA damage sites. U2OS cells expressing indicated plasmids were
treated with laser microirradiation and immunostaining with anti-gH2AX antibody. (C) PARP1 inhibitor (PJ34) suppresses the relocation of CHFR
to DNA damage sites. U2OS cells expressing GFP-CHFR were treated with laser microirradiation in the absence (PARPi) or presence (+PARPi)
of 10 mM PJ34, following immunostaining with anti-gH2AX antibody. (D) Knockdown of PARP1 signiﬁcantly suppresses the recruitment of CHFR
to DNA damage site. U2OS cells expressing GFP-CHFR were transfected with control or PARP1 siRNA. Then, cells were treated with laser
microirradiation and immunostaining with anti-gH2AX antibody. PARP1 expression following siRNA treatment is shown in the right. Histograms
in B, C and D summarize the percentage (mean±SD) of cells with GFP laser stripes colocalized with gH2AX following laser-induced DNA damage.
Data were analysed from 100 cells in each experiment from three independent experiments. Bar, 10 mm.











regulates PARP1 ubiquitination in vivo, we expressed
CHFR, the RING domain deletion or the PBZ motif
deletion mutants in HCT116 cells, which do not express
endogenous CHFR (47). PARP1 was signiﬁcantly
PARylated after IR and large amounts of ubiquitinated
PARP1 accumulated in cells expressing wild-type CHFR
in the presence of MG132 (Figure 4C and D). Neither the
RING domain deletion mutant nor the PBZ motif
deletion mutant induced PARP1 ubiquitination under
the same condition, indicating that both the E3 ligase of
CHFR and the interaction between CHFR and PAR are
important for the ubiquitination of PARP1 in vivo (Figure
4E). Moreover, the poly-ubiquitin chain on PARP1 could






























































































































































































Figure 4. CHFR ubiquitinates PARylated PARP1 and regulates the chromatin-associated PARP1 following DNA damage. (A and B) CHFR
ubiquitinates PARylated PARP1 in vitro. In vitro ubquitination assay was performed using His-PARP1 or PARylated His-PARP1 as the substrates.
Ubiquitinated proteins were examined by SDS–PAGE and western blot by using anti-PARP1, anti-PAR, anti-K48 and anti-K63 poly-ubiquitin chain
antibodies. (A) UbcH5c was used as E2 conjugase. (B) Ubc13/Uev1a was used as E2 conjugase. (C) CHFR regulates PARP1 ubiquitination in vivo.
HCT116 cells expressing myc-CHFR or mock plasmids were treated with 10Gy of IR in the presence of 10 mM MG132. PARP1 was immunopre-
cipitated from the cell lysates and subjected to SDS–PAGE and immunoblotting with anti-PARP1, anti-PAR, anti-K48 and anti-K63 poly-ubiquitin
chain antibodies. (D) HCT116 cells expressing myc-CHFR were treated with 10 Gy of IR in the absence or presence of MG132. PARP1 was
immunoprecipitated from the cell lysates and analysed by SDS–PAGE and immunoblotting with anti-PARP1 and anti-Ub (FK2) antibodies.
(E) HCT116 cells expressing myc-tagged wild-type CHFR, the RING domain or PBZ motif deletion mutants were treated with 10 Gy of IR in
the presence of MG132. PARP1 status was examined by indicated antibodies. (F) The chromatin retention of PARP1 is regulated by the E3 ligase
activity and PAR-binding ability of CHFR. The chromatin-associated PARP1 was examined at the indicated time points following 10 Gy of IR
treatments. The displacement of PARP1 from the chromatin was restored in Chfr/ MEFs reconstituted with wild-type CHFR but not the RING
domain or PBZ motif deletion mutants. Histone H4 was blotted as input control for chromatin-associated proteins. The relative amount of PARP1
in the chromatin fraction was quantitatively analysed. The data were obtained from three independent experiments and bar stands for SD. (G) The
retention of GFP-PARP1 at DNA damage sites in wild-type (WT), Chfr/ or Chfr/ MEF reconstituted with wild-type CHFR, the RING domain
deletion mutant or the PBZ motif deletion mutant was examined. The highest GFP intensity was calculated as 100% in each cell, and kinetics of the
recruitment were plotted. Data were analysed from 20 cells in each experiment. Data were presented as mean±SD. R, RING domain deletion
mutant of CHFR; P, PBZ motif deletion mutant of CHFR. Bar, 10 mm.












poly-ubiquitin chain antibodies, suggesting that CHFR
mediates a mixed poly-ubiquitin chain linkage on
PARP1. With MG132 treatment, ubiquitinated PARP1
was signiﬁcantly accumulated (Figure 4D), suggesting
that the ubiquitination of PARP1 is likely involved in
protein degradation. Consistently, we found that follow-
ing DNA damage, PARP1 quickly dissociated from the
chromatin in the wild-type cells (Figure 4F). However, in
the Chfr/ cells, the dissociation of PARP1 from the
chromatin was signiﬁcantly delayed. Moreover, when the
Chfr/ cells were reconstituted with wild-type or mutant
CHFR, only wild-type CHFR but neither the RING
domain deletion mutant nor the PBZ motif deletion
mutant facilitated the fast displacement of PARP1 from
chromatin in response to DNA damage. We also
examined the kinetics of the recruitment of PARP1 to
DNA damage sites in wild-type and in Chfr/ MEFs.
As shown in Figure 4G, PARP1 in wild-type MEFs was
quickly displaced from DNA damage sites. However, in
Chfr/ MEFs, the retention of PARP1 at DNA damage
sites was signiﬁcantly prolonged. Moreover, when Chfr/
cells were reconstituted with wild-type or mutant CHFR,
only wily type CHFR but neither the RING domain
deletion mutant nor the PBZ motif deletion mutant
restored the quick PARP1 displacement from DNA
damage sites. To conﬁrm the results, the kinetics of
PARP1 at DNA damage sites was examined in HCT116
cells. Again, the displacement of PARP1 from DNA
damage sites was signiﬁcantly faster in HCT116 cells
reconstituted with wild-type CHFR than that in mock-
transfected cells or cells reconstituted with the RING
domain or PBZ motif deletion mutants (Supplementary
Figure S5). Taken together, our results demonstrate that
both the E3 ligase activity and PAR-binding ability of
CHFR are important for the removal of PARP1 at
DNA damage sites.
CHFR participates in DNA damage repair
Removal of PAR from DNA damage sites is important
for the next step of the DNA damage repair process
(56–60). Since PARP1 is the major enzyme to synthesize
PAR at DNA damage sites, the eviction of PARP1 is
15 min 20 min 40 min
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likely to be critical for the next step of DNA damage
repair. To study the role of CHFR-dependent PARP1
eviction in the DNA damage response, we measured
DNA damage repair kinetics in the Chfr/ and wild-
type MEFs by comet assay under alkaline condition. As
shown in Figure 5A, within 2 h following low dose IR
treatment (5Gy), most DNA damage sites, including
single- and double-strand breaks, as well as alkali-labile
sites, were repaired in wild-type MEFs but not in Chfr/
MEFs. Moreover, Chfr/ MEFs reconstituted with wild-
type CHFR, but not the RING domain deletion mutant
nor the PBZ motif deletion mutant, rescued the DNA
damage repair defects (Figure 5A), suggesting that both
the E3 ligase activity of CHFR and the PAR-binding of
CHFR are important for the DNA damage repair. We
also depleted PARP1 expression with siRNA in wild-
type and Chfr/ MEFs. In wild-type MEFs, PARP1 de-
pletion caused mild DNA damage repair defects in control
MEFs, suggesting that PARP1 itself is important for
DNA damage repair. However, in Chfr/ MEFs, deple-
tion of PARP1 partially rescued the DNA damage repair
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Figure 5. CHFR protects against DNA damage. (A) Representative microphotographs of comet assay at indicated time points following 5 Gy of IR
treatment. Cells with indicated genotypes were subjected to alkali comet assays. Tail moments were summarized from three independent experiments
with at least 50 cells in single time point per sample. Data were presented as mean±SD. PARP1’s expression in WT and Chfr/ MEFs after
siRNA treatment was shown in the lower right panel. (B) CHFR-deﬁcient MEFs are sensitive to IR. Cells with indicated genotypes were subjected to
cell survival assay. Data were presented as mean±SD from three independent experiments. (C) A model of CHFR recruited by PAR and
ubiquitinating PARP1 at DNA damage sites. R, RING domain deletion mutant of CHFR; P, PBZ motif deletion mutant of CHFR.











from the chromatin is important for the DNA repair
process, and CHFR-dependent PARP1 ubiquitination fa-
cilitates the dissociation of PARP1 from the chromatin
following DNA damage. We conﬁrmed these results
using a long-term cell viability assay. Again, we found
that both the E3 ligase activity of CHFR and the
PAR-binding of CHFR are important for DNA damage
repair. Moreover, depletion of PARP1 partially rescued
the DNA damage repair defect in Chfr/ MEFs
(Figure 5B).
DISCUSSION
In this study, we demonstrated that CHFR is one of the
earliest E3 ligases recruited to DNA damage sites. This
cellular process is mediated by the interaction between
the PBZ motif of CHFR and PAR at DNA damage
sites. The CHFR-dependent protein ubiquitination repre-
sents the ﬁrst wave of protein ubiquitination at DNA
damage sites. Here, we show evidence that CHFR can
ubiquitinate PARylated PARP1, which might be import-
ant for its displacement from DNA damage sites (Figure
5C). Following DNA damage, massive protein
PARylation occurs at DNA damage sites catalyzed
mainly by PARP1 and the major substrate of protein
PARylation is PARP1 itself (52,61–63), which is import-
ant for chromatin relaxation (64). Recent studies suggest
that PAR at DNA damage sites recruit DNA damage
repair proteins to DNA lesions to fulﬁll their repair
function (65–72). Meanwhile, the hyper-activated
PARP1 may deplete intracellular pools of NAD+, result-
ing in impaired ATP production and genomic instability
(73–76). Thus, the activity of PARP1 during the DNA
damage response needs to be tightly controlled.
Poly(ADP-ribose) glycohydrolase (PARG) is recruited to
DNA damage sites and plays a critical role in hydrolyzing
PAR and recycling PARP1 during DNA damage response
(67,77,78). Thus, PARP1 has to be removed from DNA
damage sites, or degraded to prevent the recycling of
PARP1 through PARG. This process is to avoid the con-
tinuous activation of PARP1 during DNA damage
response. Here, our results suggest that CHFR-dependent
ubiquitination is important for the eviction of PARP1
from DNA damage sites for proteasomal degradation.
This is one of the mechanisms by which cells control the
activated PARP1 in response to DNA damage.
In addition to PARP1, CHFR may also ubiquitinate
other substrates, such as nucleosomal histones (39).
Interestingly, histones can be also PARylated by PARP1
in response to DNA damage (61,62,64,79). Thus, it is
likely that CHFR ubiquitinates PARylated histones at
DNA damage sites, which facilitates histone eviction at
DNA damage sites. It would allow other DNA damage
repair proteins to access DNA lesions for the next step of
DNA damage repair. Removal of PARylated histones
might also promote the displacement of CHFR from
DNA damage sites.
Using mouse genetic approaches, we have demonstrated
that CHFR and RNF8 additively regulate the DNA
damage response and maintain genomic stability (39).
The RING domains of CHFR and RNF8 are inter-
changeable (41). Both CHFR and RNF8 ubiquitinate
histones and may share other substrates. However, the mo-
lecular mechanism of recruitment of these two E3 ligases are
different, which determines that CHFR reaches DNA
damage sites earlier than RNF8. Thus, CHFR-dependent
protein ubiquitination represent the ﬁrst wave of protein
ubiquitination at DNA damage sites. Loss of CHFR only
delays protein ubiquitination but not abolish protein
ubiquitination, suggesting that RNF8- and the RNF8-
dependent ubiquitin cascade have a redundant role of
CHFR at DNA damage sites. Thus, it is possible that
PARP1 eviction from DNA damage sites may also be
regulated by RNF8- and the RNF8-dependent ubiquitin
cascade in the absence of CHFR, albeit in a delayed
manner. However, following loss of both CHFR and
RNF8, protein ubiquitination is completely abolished at
DNA damage sites, which signiﬁcantly suppresses the
DNA damage response and induces genomic instability (39).
Interestingly, in human cancer cells, it is CHFR but not
RNF8 that is often silenced (40,43,47). Although this selec-
tion mechanism is not clear, long-term loss of CHFR
prolongs the retention of PARP1 at DNA damage sites,
which may induce the accumulation of DNA lesions and
facilitate tumourigenesis. PARP1 inhibitor treatment could
antagonize the defects generated by the prolonged PARP1
at DNA damage sites. Thus, it is possible that PARP in-
hibitors could be used in chemoprevention to suppress
CHFR-deﬁciency-induced tumourigenesis. During the
preparation of this article, Kashima et al. (80) reported
that CHFR interacts with and ubiquitinates unmodiﬁed
PARP1 during mitosis, although the function of PARP1
in mitosis remains elusive. In our study, we found that
CHFR only recognizes PAR instead of unmodiﬁed
PARP1. Since PAR is massively synthesized at DNA
damage sites, this interaction induces the relocation of
CHFR to DNA damage sites and facilitates the removal
of PARP1 from the chromatin through ubiquitination. This
process is important for DNA damage repair. Moreover,
distinct from the previous report, CHFR only ubiquitinates
PARylated PARP1 but not unmodiﬁed PARP1. Since
PARP1 is heavily PARylated in response to DNA
damage, we found that CHFR induced ubiquitination of
PARylated PARP1 following DNA damage. But lacking
CHFR did not alter the expression of PARP1 under
normal conditions (Supplementary Figure S6).
Consistently, we found that recombinant CHFR only inter-
acts with PARylated PARP1 but does not recognize un-
modiﬁed PARP1 (Supplementary Figure S4).
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Supplementary Data are available at NAR Online:
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